首页> 外文期刊>Sleep medicine >What's next after the exciting discovery and reassuring replications of genome-wide association studies of restless legs syndrome?
【24h】

What's next after the exciting discovery and reassuring replications of genome-wide association studies of restless legs syndrome?

机译:在令人不安的腿综合征的全基因组关联研究令人兴奋的发现和令人放心的复制之后,下一步是什么?

获取原文
获取原文并翻译 | 示例
       

摘要

Two previous consecutive genome-wide association studies (GWASs) have identified and confirmed four genomic regions significantly associated with restless legs syndrome (RLS) in German, Austrian, and French-Canadian case-control samples [1,2]. These four candidate regions include the MEIS1 gene on chromosome 2p, the BTBD9 gene on chromosome 6p, the overlapped region between the MAP2K5 and SKOR1 genes on chromosome 15q, and the PTPRD gene on chromosome 9p. Most recently, a third extended GWAS of RLS has reconfirmed the same allelic associations of these previously reported common variants with RLS in more diverse Caucasian populations from Europe and North America, in addition to the detection of two new loci in much larger German and Austrian samples, i.e., an intergenic region on chromosome 2pl4 (1.3 Mb downstream of the MEIS1 gene) and a locus on 16ql2.1 (close to the TOX3 gene and the non-coding RNA BC034767) [3]. Altogether, the common variants from these six genomic loci, consistently detected in the RLS GWASs [1-4], and confirmed in the concurrent [1-3] and subsequent independent replication studies [5-8], confer small to modest relative risks to RLS (OR: 1.2-1.8), and could give rise to a maximum area under the curve (AUC) of 0.65 for the receiver operator characteristic (ROC), based on a weighted risk allele score for genetic risk prediction [3], which is below the threshold (AUC >= 0.75) as a useful clinical diagnostic classifier when applied to at-risk individuals, e.g., family members of RLS patients [9], Furthermore, common variants from these six RLS-associated loci could only explain 6.8% of the total genetic variance [3], Therefore, the majority of the RLS heritability estimated from previous twin and family studies [10-12] is still missing and/ or hidden. The fact that the common variants detected through GWASs do not explain all the heritability is not a unique situation for RLS but rather a general phenomenon for most of the GWASs of complex dis...
机译:先前的两项连续的全基因组关联研究(GWAS)已在德国,奥地利和法国-加拿大的病例对照样本中确定并确认了四个与不安腿综合征(RLS)显着相关的基因组区域[1,2]。这四个候选区域包括染色体2p上的MEIS1基因,染色体6p上的BTBD9基因,染色体15q上的MAP2K5和SKOR1基因之间的重叠区域以及染色体9p上的PTPRD基因。最近,RLS的第三个扩展GWAS再次确认了这些先前报道的常见变异与欧洲和北美更多白种人人群中RLS的等位基因关联,此外,在德国和奥地利样本中检测到两个新基因座,即染色体2pl4上的一个基因间区域(MEIS1基因的下游1.3 Mb)和16ql2.1上的一个基因座(靠近TOX3基因和非编码RNA BC034767)[3]。总之,在RLS GWAS [1-4]中始终检测到并在并发[1-3]和随后的独立复制研究[5-8]中确认的来自这六个基因组位点的常见变体具有较小或中等的相对风险。到RLS(OR:1.2-1.8),并且基于遗传风险预测的加权风险等位基因得分,可以使接收者操作者特征(ROC)的最大曲线面积(AUC)达到0.65 [3],当应用于有风险的个体(例如,RLS患者的家庭成员)时,该值低于阈值(AUC> = 0.75)作为有用的临床诊断分类器[9]。此外,这6个与RLS相关的基因座的常见变异只能解释总遗传变异的6.8%[3],因此,根据先前的双胞胎和家族研究[10-12]估算的大部分RLS遗传力仍然缺失和/或隐藏。通过GWAS检测到的常见变体并不能解释所有遗传性这一事实对于RLS而言并不是唯一的情况,而是大多数复杂疾病的GWAS的普遍现象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号